课题基金 / 基金详情

Mechanisms of Hepatic Steatosis Prevention

Mechanisms of Hepatic Steatosis Prevention
预防肝脏脂肪变性的机制
批准号:
7556373
负责人:
MARK PUDER
金额:
$12.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-02-28

项目摘要

项目成果

MARK PUDER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Parental nutrition is life-saving but may produce severe liver injury, resulting in high morbidity and mortality in children. Long-term parenteral nutrition may also produce a slowly progressive liver injury in many adults. Since the development of parenteral nutrition over thirty years ago, there have been few improvements in the prevention and treatment of this liver injury. My primary career objective is to become an independent investigator conducting basic and translational research that advances the development of new therapies in the prevention and treatment of this often-fatal complication of parenteral nutrition. As steps toward this goal, I hope to gain additional training in basic lipid metabolism and the broad field of the biochemistry of matrix metalloproteinases. To guide me in my pursuit of these goals, I have chosen two outstanding recognized mentors and scientists, Dr. Bruce Bistrian and Dr. Marsha Moses. Together with Dr. Judah Folkman, they will also form my advisory committee. I have arranged for courses, conferences and meetings to complement these goals. My proposed research focuses on three aims. First, I intend to determine how matrix metalloproteinase inhibitors prevent steatosis and liver injury in our animal model utilizing in vivo lipid studies and in vitro enzymatic methods to study lipid synthesis, oxidation, and secretion of triglycerides from the liver. Second, I intend to determine the role of specific cytokines in the development of steatosis and its prevention utilizing genetically manipulated mice with and without matrix metalloproteinase inhibitors. Third, I intend to determine the transcription, protein levels, and enzymatic activity of specific metalloproteinases important in the development, prevention, and reversal of steatosis and steatohepatitis. This award would provide me with protected time to pursue these research and training objectives, and greatly facilitate my transition to an independent researcher in the study of this devastating disease
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.physbeh.2010.04.001
发表时间: 2010-06-16
期刊: PHYSIOLOGY & BEHAVIOR
影响因子: 2.9
作者: [de Meijer, Vincent E., Le, Hau D., Meisel, Jonathan A., Puder, Mark]
通讯作者: Puder, Mark
Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients.
肠胃外鱼类作为单一疗法可防止肠胃外营养依赖性患者的必需脂肪酸缺乏。
DOI: 10.1097/mpg.0b013e3181bbf51e
发表时间: 2010-02
期刊: Journal of pediatric gastroenterology and nutrition
影响因子: 2.9
作者: [de Meijer VE, Le HD, Meisel JA, Gura KM, Puder M]
通讯作者: Puder M
DOI: 10.1016/j.metabol.2009.11.006
发表时间: 2010-08
期刊: METABOLISM-CLINICAL AND EXPERIMENTAL
影响因子: 9.8
作者: [de Meijer, Vincent E., Le, Hau D., Meisel, Jonathan A., Sharif, M. Reza Akhavan, Pan, Amy, Nose, Vania, Puder, Mark]
通讯作者: Puder, Mark
Tumor necrosis factor α-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in mice.
肿瘤坏死因子α转化酶抑制作用逆转肝脂肪变性,并改善小鼠的胰岛素敏感性标志物和手术结果。
DOI: 10.1371/journal.pone.0025587
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者: [de Meijer VE, Le HD, Meisel JA, Sharma AK, Popov Y, Puder M]
通讯作者: Puder M
6
    Cholestasis Reversal (Phase ll): Efficacy of lV Fish Oil
    • 批准号:
      7617606
    • 项目类别:
    • 资助金额:
      $26.38万
    • 财政年份:
      2008
    • 负责人:
      MARK PUDER
    • 依托单位:
    Cholestasis Reversal (Phase ll): Efficacy of lV Fish Oil
    • 批准号:
      7843584
    • 项目类别:
    • 资助金额:
      $28.7万
    • 财政年份:
      2008
    • 负责人:
      MARK PUDER
    • 依托单位:
    海外基金